We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
No fiscal-year history available for this company yet.
No P/E, the company is not profitable on a trailing basis.
Established in 1989 and headquartered in Vadodara, India, Sudeep Pharma Limited specializes in the manufacturing and distribution of excipients and unique ingredients. The company serves the pharmaceutical, food, and nutrition sectors, with a market reach extending across the United States, Europe, the United Kingdom, and Latin America. Its product range includes essential mineral salts such as calcium, zinc, iron, potassium, magnesium, sodium, and copper, which are vital for a variety of health-focused applications. Sudeep Pharma also provides calcium carbonate, utilized as an active pharmaceutical ingredient in diverse therapeutic contexts. Furthermore, the company develops and supplies advanced nutrient formulations, including micronutrient premixes, encapsulated ingredients, liposomal and spray-dried formats, granulated minerals, and triturated blends. These innovative solutions are designed for applications in functional foods, dietary supplements, infant and clinical nutrition, fast-moving consumer goods, and convenience food products. Beyond production, Sudeep Pharma's extensive operations encompass the development, trade, import, export, and processing of a broad spectrum of pharmaceuticals, nutraceuticals, food ingredients, and vitamin/mineral blends for human and animal nutrition, alongside other chemical and healthcare products.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save SUDEEPPHRM.NS and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
